Literature DB >> 10693867

Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.

D H Manicourt1, P Poilvache, A Van Egeren, J P Devogelaer, M E Lenz, E J Thonar.   

Abstract

OBJECTIVE: To compare synovial fluid (SF) levels of oncostatin M (OSM), tumor necrosis factor alpha (TNFalpha), and interleukin-6 (IL-6) in patients with rheumatoid arthritis (RA) and osteoarthritis (OA) and to determine which correlate best with SF levels of antigenic keratan sulfate (Ag KS), a marker of aggrecan catabolism, and pyridinium crosslinks, markers of the degradation of mature collagen molecules.
METHODS: SF was drawn from the knee joints of patients with RA (n = 31) or OA (n = 31). Levels of Ag KS, D-pyridinoline (D-Pyr), pyridinoline (Pyr), OSM, TNFalpha, and IL-6 were measured by enzyme-linked immunosorbent assay.
RESULTS: RA patients had higher median SF levels of OSM, TNFalpha, IL-6, and Pyr, but a lower median level of D-Pyr, than OA patients. In both groups, IL-6 levels correlated positively with those of OSM and TNFalpha. However, the correlation between levels of OSM and TNFalpha was only significant in the RA group. Ag KS and Pyr levels correlated positively in RA but not in OA. The correlation between TNFalpha and Ag KS was positive in RA and negative in OA. Further, in RA, OSM and IL-6 levels correlated strongly with Pyr and Ag KS levels but not with D-Pyr levels, while there were no strong correlations in OA for OSM or IL-6 levels with Pyr, Ag Ks, or D-Pyr levels.
CONCLUSION: This in vivo study suggests that TNFalpha and other proinflammatory cytokines are involved in the up-regulation of the coordinated degradation of cartilage aggrecan and collagen in RA. Further, OSM may act synergistically with other proinflammatory cytokines in up-regulating the production of metalloproteinases by chondrocytes in rheumatoid joints.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10693867     DOI: 10.1002/1529-0131(200002)43:2<281::AID-ANR7>3.0.CO;2-7

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  38 in total

Review 1.  Future prospects for anti-cytokine treatment.

Authors:  M Feldmann; J Miotla; E Paleolog; R Williams; A M Malfait; P Taylor; F M Brennan; R N Maini
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

2.  Cyclic adenosine 5'-monophosphate in synovial fluid of rheumatoid arthritis and osteoarthritis patients.

Authors:  Jadranka Morovic-Vergles; Melanie Ivana Culo; Stjepan Gamulin; Filip Culo
Journal:  Rheumatol Int       Date:  2008-08-10       Impact factor: 2.631

3.  Lentivirus-induced knockdown of LRP1 induces osteoarthritic-like effects and increases susceptibility to apoptosis in chondrocytes via the nuclear factor-κB pathway.

Authors:  Erping Yang; Huifeng Zheng; Hao Peng; Yinyuan Ding
Journal:  Exp Ther Med       Date:  2015-05-05       Impact factor: 2.447

4.  75-kd sirtuin 1 blocks tumor necrosis factor α-mediated apoptosis in human osteoarthritic chondrocytes.

Authors:  Hanna Oppenheimer; Odile Gabay; Hadar Meir; Amir Haze; Leonid Kandel; Meir Liebergall; Viktoria Gagarina; Eun Jin Lee; Mona Dvir-Ginzberg
Journal:  Arthritis Rheum       Date:  2012-03

5.  Effect of estrogen on the expression of matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 and tissue inhibitor of metalloproternase-1 in osteoarthritis chondrocytes.

Authors:  Yun Jong Lee; Eun Bong Lee; Young Ee Kwon; Jung Jin Lee; Woo Shin Cho; Hyun A Kim; Yeong Wook Song
Journal:  Rheumatol Int       Date:  2003-04-09       Impact factor: 2.631

6.  Computational deconvolution of synovial tissue cellular composition: presence of adipocytes in synovial tissue decreased during arthritis pathogenesis and progression.

Authors:  Wenhui Wang; Li Wang; Percio S Gulko; Jun Zhu
Journal:  Physiol Genomics       Date:  2019-05-17       Impact factor: 3.107

7.  The underlying inflammatory chronic disease influences infliximab pharmacokinetics.

Authors:  Christophe Passot; Denis Mulleman; Theodora Bejan-Angoulvant; Alexandre Aubourg; Stephanie Willot; Thierry Lecomte; Laurence Picon; Philippe Goupille; Gilles Paintaud; David Ternant
Journal:  MAbs       Date:  2016-08-09       Impact factor: 5.857

8.  Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand.

Authors:  Alfons S K de Hooge; Fons A J van de Loo; Miranda B Bennink; Diana S de Jong; Onno J Arntz; Erik Lubberts; Carl D Richards; Wim B vandDen Berg
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

9.  Disease-specific proteins from rheumatoid arthritis patients.

Authors:  Choong Won Kim; Eun Hye Cho; Yun Jong Lee; Yoon Hee Kim; Young Sool Hah; Deok Ryong Kim
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

10.  A novel distal enhancer mediates cytokine induction of mouse RANKl gene expression.

Authors:  Kathleen A Bishop; Mark B Meyer; J Wesley Pike
Journal:  Mol Endocrinol       Date:  2009-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.